Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul-Sep;19(3):339-43.
doi: 10.4103/0972-2327.179973.

Polycystic ovary syndrome in patients on antiepileptic drugs

Lakshminarayanapuram G Viswanathan  1 , Parthasarathy Satishchandra  1 , Bipin C Bhimani  1 , Janardhan Yc Reddy  2 , Batchu S Rama Murthy  3 , Doddaballapura K Subbakrishna  4 , Sanjib Sinha  1
Affiliations

Polycystic ovary syndrome in patients on antiepileptic drugs

Lakshminarayanapuram G Viswanathan et al. Ann Indian Acad Neurol. 2016 Jul-Sep.

Abstract

Objective: This study aims to discuss the prevalence of polycystic ovary (PCO) and Polycystic ovary syndrome (PCOS) in women with epilepsy (WWE) on valproate (VPA), carbamazepine (CBZ), or phenobarbitone (PB), drug naive WWE and women with bipolar affective disorder (BPAD) on VPA.

Materials and methods: This prospective study included 190 women aged 18-45 years, who had epilepsy or BPAD (on VPA), and consented for study. Patients were grouped as Group 1 (n = 40): WWE on VPA, Group 2 (n = 50): WWE on CBZ, Group 3 (n = 50): WWE on PB, Group 4 (n = 30): drug naïve WWE, and Group 5 (n = 20): women with BPAD on VPA. All women were interviewed for medical, menstrual, drug and treatment history, nature of epilepsy, and seizure control. Chi-square test and Fisher's exact test were done to compare results between the groups.

Results: Fifty-two women (52/190; 27.4%) had menstrual disturbances, in which oligomenorrhea was the most common (55.8%). There was a significant difference in the occurrence of PCOS in patients on VPA versus normal population (P = 0.05) and patients on other antiepileptic drugs (AEDs) (P = 0.02). There was, however, no significant difference in the occurrence of PCO between patients on VPA and the untreated epileptic women. VPA group (Epilepsy + BPAD) had a significantly higher occurrence of obesity than other treatment groups (P = 0.043, OR = 2.11).

Conclusions: The study observed significantly higher occurrence of PCO in patients on VPA compared to other AEDs and the normal population. The importance of proper clinical evaluation before initiating VPA is highlighted.

Keywords: Antiepileptic drugs; Polycystic ovary syndrome; epilepsy; valproate.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Thomas S. Managing epilepsy in pregnancy. Neurology India. 2011;59:59. - PubMed
    1. Singh M, Singh P, Cugati G, Singh A. Effect of epilepsy on female fertility and reproductive abnormalities. Journal of Human Reproductive Sciences. 2011;4:100. - PMC - PubMed
    1. Polson D, Wadsworth J, Adams J, Franks S. Polycystic ovaries: A common finding in normal women. The Lancet. 1988;331:870–2. - PubMed
    1. Adams J, Polson D, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ. 1986;293:355–9. - PMC - PubMed
    1. Sahota P, Prabhakar S, Kharbanda P, Bhansali A, Jain V, Das C, et al. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: A cross-sectional study. Epilepsia. 2008;49:2069–77. - PubMed